, Singapore
397 views
Logo from Healthway Medical

OUE Healthcare declares unconditional its offer to delist Healthway Medical

It has received valid acceptances amounting to 2,289,294,145 shares.

OUE Healthcare has declared its offer to take Healthway Medical private at  $0.048 per share "unconditional."

Oversea-Chinese Banking Corporation Limited (OCBC Bank), on behalf of OUE Healthcare, said the company received valid acceptances amounting to 2,289,294,145 shares, representing 50.47% of Healthway's Medical's total number of issued shares, making the offer unconditional as to the level of acceptances.

OCBC, however, said that the exit offer has not become "unconditional in all respects" as the proposed offeree resolutions have not yet been approved at Healthway Medical's extraordinary general meeting which will be held on 28 September.

OUE Healthcare's offer will remain open for acceptance for at least 14 days after the date of the announcement of the shareholders' delisting approval is obtained.

"Accordingly, the closing date for the exit offer will be 5.30 p.m. (Singapore time) on 12 October 2023, or such later time(s) and date(s) as may be announced from time to time by or on behalf of the offeror," OCBC said.

Join Singapore Business Review community

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.